MedPath
HSA Approval

SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9%

SIN06282P

SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9%

SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9%

June 11, 1991

LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED

LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantLUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED
Licence HolderLUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05XA03

sodium chloride

Manufacturer Information

LUEN WAH MEDICAL COMPANY (SINGAPORE) PRIVATE LIMITED

P T OTSUKA INDONESIA

Active Ingredients

SODIUM CHLORIDE

0.9 g/100 ml

Sodium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9% - HSA Approval | MedPath